COMMUNIQUÉS West-GlobeNewswire

Fluidigm Becomes the First Company to Enable 50-Plex Cytometry Panels with the Release of Seven New Metal Antibody Labels
24/09/2019
Powering industry-leading CyTOF technology to deliver new insights in translational and clinical research SOUTH SAN FRANCISCO, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative [...]
Dr. Frank Gerberick, Procter & Gamble Product Safety Veteran, Joins RenovaCare
24/09/2019
SCOTTSDALE, Ariz., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and [...]
AgraFlora Organics présente une mise à jour opérationnelle et des détails sur l’obtention de la licence de vente pour son installation de production de cannabis artisanal AAA Heidelberg
24/09/2019
VANCOUVER, Colombie-Britannique, 24 sept. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]
Vaccinex to Present at the Ladenburg Thalmann 2019 Healthcare Conference
24/09/2019
ROCHESTER, N.Y., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today [...]
Salarius Pharmaceuticals Achieves Dose-Escalation Milestones in Ongoing Phase 1/2 Ewing Sarcoma and Phase 1 Advanced Solid Tumor Clinical Trials
24/09/2019
Fourth Level Dosing Cohorts Now Proceeding Following Safety Review Committee Clearance HOUSTON, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company [...]
Philips announces availability of expanded SmartSleep suite of solutions in U.S. market
24/09/2019
September 24, 2019 Consumer offerings aim to ultimately address approximately 80 percent of all sleep issues worldwide Collaborative efforts with Walgreens, WebMD enhance consumer access to sleep information and [...]
Progressive Care Inc. Announces $3.7 Million Gross Revenue for August 2019
24/09/2019
MIAMI, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
HealthLynked Corp. Announces the Launch of New Website
24/09/2019
NAPLES, Fla., Sept. 24, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), a nationwide healthcare network focused on improving healthcare through technology that connects doctors, patients and medical data, is [...]
R1 RCM Appoints Richard Evans as Interim CFO
24/09/2019
Follows Resignation of Christopher Ricaurte Raises 2019 Adjusted EBITDA Outlook CHICAGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) [...]
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension
24/09/2019
NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx
24/09/2019
Partnership Will Enable Physicians to Order Clinical Immunodiagnostic Testing that Can Be Performed in Local Laboratories SEATTLE, Wash., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: [...]
BayCare Health System to Present on Improved Pharmacy Operations Using DoseMeRx and Cerner Electronic Health Record at Cerner Health Conference 2019
24/09/2019
MOORESTOWN, N.J., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (Nasdaq: TRHC) , a healthcare technology company advancing the field of medication safety, today announced its subsidiary DoseMe [...]
Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome
24/09/2019
Data Published for First Time in Peer-Reviewed Journal REDWOOD CITY, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing [...]
CareDx Adds HistoMap To Testing Portfolio
24/09/2019
CareDx partners with NanoString to improve precision of transplant biopsies BRISBANE, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery [...]
Spectral Medical Launches the Tigris Trial
24/09/2019
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( “Spectral” or the “Company” ) (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion [...]
REPEAT - AgraFlora Organics Provides Operational Update and Sales License Guidance at AAA Heidelberg Craft Cannabis Facility
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Avadel Pharmaceuticals Announces Pharmacokinetic (PK) Data for Once-Nightly FT218 that will be Included in an Oral Presentation at the World Sleep 2019 Congress on September 25th
24/09/2019
DUBLIN, Ireland, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, for narcolepsy, today [...]
Auxly Announces Closing of Previously Announced $84 Million Credit Facilities Through its Joint Venture Partner, Sunens Farms Inc.
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“ Sunens [...]
Capricor Therapeutics to Meet with FDA to Discuss CAP-1002 to Treat Duchenne Muscular Dystrophy
24/09/2019
Company Exploring Potential for Accelerated Approval under RMAT Designation, an Expedited Program for Regenerative Therapies LOS ANGELES, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a [...]

Pages